Charta SRL
Charta reported total assets of 422,145 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Charta shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +50 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Charta's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 28,523 € | ||||
| Equity | 74,612 € | ||||
| Cash | 56,920 € | ||||
| EBITDA | 55,998 € | ||||
| Total assets | 422,145 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 22 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 13 Mar 2024
- Year ended 31 Dec 2021filed on 07 Aug 2023
Charta's financial analysis
- Solvency17.7%sector median: 48.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Charta
Charta's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0448.682.507
- VAT number
- BE0448682507
- Peppol
- Registered · 0208:0448682507 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Nov 1992
- Registered office
- 5030 Gembloux
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Manufacture of other inorganic basic chemicals (NACE 20130)
Charta (SRL) has been based in Gembloux since 1992, active in: manufacture of other inorganic basic chemicals. For 2025, it reports a net profit of 28,523 € and equity of 74,612 €; its revenue is not published. Its solvency stands at 17.7%, below the median of its sector (48.5%).
Companies similar to Charta
Companies in the same business, of comparable size and area, outside its group.
- L - Pharma Manufacture of pharmaceutical preparations Turnhout · balance sheet 10 €
- RTLC Manufacture of pharmaceutical preparations Brussels · balance sheet 107,167 €
- Promacon Manufacture of basic pharmaceutical products Hove · balance sheet 408,759 €
- Oropharma Manufacture of pharmaceutical preparations Deinze · balance sheet 352,437 €
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
- Jethan Chemicals Manufacture of other inorganic basic chemicals Laarne · balance sheet 298,902 €
- Laboratoires Sopreli Manufacture of pharmaceutical preparations Anderlecht · balance sheet €1.10m
- Alchemich Farma Manufacture of pharmaceutical preparations Houthalen-Helchteren · balance sheet 258,120 €
Frequently asked questions about Charta
What is the revenue of Charta?
Charta files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Charta?
In Belgium, the VAT number is the company number prefixed with BE: BE0448682507 for Charta, if the company is VAT-registered. Its company number (CBE) is 0448.682.507.
Where is the registered office of Charta?
According to the CBE register, the registered office of Charta is in 5030 Gembloux.
What is the equity of Charta?
At the close of the 2025 financial year, the equity of Charta amounts to 74,612 €, a solvency of 17.7% of total assets.
Who manages Charta?
The register lists 2 active mandates at Charta. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Charta
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →